Yeast extracts for transfer RNA gene transcription and processing.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 2199761)

Published in Methods Enzymol on January 01, 1990

Authors

C F Evans, D R Engelke

Articles by these authors

Specific interaction of a purified transcription factor with an internal control region of 5S RNA genes. Cell (1980) 10.87

Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol (1995) 3.90

Purification and characterization of the nuclear RNase P holoenzyme complex reveals extensive subunit overlap with RNase MRP. Genes Dev (1998) 2.97

Nucleolar localization of early tRNA processing. Genes Dev (1998) 2.78

Nucleolytic processing of a tRNAArg-tRNAAsp dimeric precursor by a homologous component from Saccharomyces cerevisiae. J Biol Chem (1985) 2.52

HeLa cell RNA polymerase III transcription factors. Functional characterization of a fraction identified by its activity in a second template rescue assay. J Biol Chem (1984) 2.15

Streptavidin aptamers: affinity tags for the study of RNAs and ribonucleoproteins. RNA (2001) 2.11

tRNA genes as transcriptional repressor elements. Mol Cell Biol (1994) 2.10

Characterization of RPR1, an essential gene encoding the RNA component of Saccharomyces cerevisiae nuclear RNase P. Mol Cell Biol (1991) 1.82

Comparative structural analysis of nuclear RNase P RNAs from yeast. J Biol Chem (1993) 1.71

Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther (1997) 1.71

An RNase P RNA subunit mutation affects ribosomal RNA processing. Nucleic Acids Res (1996) 1.67

A CBF5 mutation that disrupts nucleolar localization of early tRNA biosynthesis in yeast also suppresses tRNA gene-mediated transcriptional silencing. Proc Natl Acad Sci U S A (2000) 1.62

Copper-induced binding of cellular factors to yeast metallothionein upstream activation sequences. Proc Natl Acad Sci U S A (1989) 1.56

5' processing of tRNA precursors can Be modulated by the human La antigen phosphoprotein. Mol Cell Biol (1998) 1.49

Partial characterization of an RNA component that copurifies with Saccharomyces cerevisiae RNase P. Mol Cell Biol (1989) 1.48

Direct identification of small sequence changes in chromosomal DNA. Gene (1986) 1.46

Genomic footprinting of a yeast tRNA gene reveals stable complexes over the 5'-flanking region. Mol Cell Biol (1989) 1.45

Expression of RNase P RNA in Saccharomyces cerevisiae is controlled by an unusual RNA polymerase III promoter. Proc Natl Acad Sci U S A (1991) 1.43

Structure-sensitive RNA footprinting of yeast nuclear ribonuclease P. Biochemistry (1994) 1.39

Comparison of tRNA gene transcription complexes formed in vitro and in nuclei. Mol Cell Biol (1987) 1.37

Probing RNA structure with chemical reagents and enzymes. Curr Protoc Nucleic Acid Chem (2001) 1.29

An essential protein-binding domain of nuclear RNase P RNA. RNA (2001) 1.28

CTL escape viral variants. I. Generation and molecular characterization. Virology (1995) 1.27

Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. J Virol (1996) 1.26

Nuclear pre-tRNA terminal structure and RNase P recognition. RNA (1997) 1.17

ACE1 transcription factor produced in Escherichia coli binds multiple regions within yeast metallothionein upstream activation sequences. Mol Cell Biol (1990) 1.16

CTL escape viral variants. II. Biologic activity in vivo. Virology (1995) 1.15

Sephadex-binding RNA ligands: rapid affinity purification of RNA from complex RNA mixtures. Nucleic Acids Res (2001) 1.12

Effects of 5' leader and 3' trailer structures on pre-tRNA processing by nuclear RNase P. Biochemistry (2000) 1.09

Replacement of the Saccharomyces cerevisiae RPR1 gene with heterologous RNase P RNA genes. Nucleic Acids Res (1994) 1.09

Mutational analysis of Saccharomyces cerevisiae nuclear RNase P: randomization of universally conserved positions in the RNA subunit. RNA (1996) 1.08

Yeast expression vectors using RNA polymerase III promoters. Gene (1994) 1.08

Direct sequence and footprint analysis of yeast DNA by primer extension. Methods Enzymol (1991) 1.08

Detailed in vivo analysis of interferon-gamma induced major histocompatibility complex expression in the the central nervous system: astrocytes fail to express major histocompatibility complex class I and II molecules. Lab Invest (1999) 1.06

In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. Am J Pathol (2001) 1.04

Eukaryotic ribonuclease P: increased complexity to cope with the nuclear pre-tRNA pathway. J Cell Physiol (2001) 1.02

Evidence for an RNA-based catalytic mechanism in eukaryotic nuclear ribonuclease P. RNA (2000) 1.01

DNA ligands that bind tightly and selectively to cellobiose. Proc Natl Acad Sci U S A (1998) 1.00

Characterization of two active site mutations of thioredoxin reductase from Escherichia coli. J Biol Chem (1989) 0.98

Gal4 protein binding is required but not sufficient for derepression and induction of GAL2 expression. J Biol Chem (1993) 0.95

A conserved RNA motif involved in divalent cation utilization by nuclear RNase P. RNA (1996) 0.93

Homologous in vitro transcription of linear DNA fragments containing the tRNAArg-tRNAAsp gene pair from Saccharomyces cerevisiae. DNA (1984) 0.89

Eukaryotic nuclear RNase P: structures and functions. Prog Nucleic Acid Res Mol Biol (1996) 0.88

Multiple forms of DNA-dependent RNA polymerases in Xenopus laevis. Rapid purification and structural and immunological properties. J Biol Chem (1983) 0.88

Protein-DNA interactions in vivo--examining genes in Saccharomyces cerevisiae and Drosophila melanogaster by chromatin footprinting. Methods Cell Biol (1991) 0.87

Limiting the available T cell receptor repertoire modifies acute lymphocytic choriomeningitis virus-induced immunopathology. J Neuroimmunol (1994) 0.87

Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy. J Virol (1999) 0.85

Effects of phosphorothioate modifications on precursor tRNA processing by eukaryotic RNase P enzymes. J Mol Biol (2000) 0.85

Initiation of rrn transcription in chloroplasts of Euglena gracilis bacillaris. Curr Genet (1988) 0.81

Saccharomyces cerevisiae nuclear ribonuclease P: structure and function. Methods Enzymol (2001) 0.80

Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol Rev (1996) 0.80

Structural analysis of the P10/11-P12 RNA domain of yeast RNase P RNA and its interaction with magnesium. Biochemistry (1998) 0.78

Markers of central nervous system glia and neurons in vivo during normal and pathological conditions. Curr Top Microbiol Immunol (2002) 0.78

Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. Curr Top Microbiol Immunol (1996) 0.77

An active domain of the nuclear RNase P RNA. Nucleic Acids Symp Ser (1997) 0.77

Synthesis of small RNA transcripts with discrete 5' and 3' ends. Biotechniques (1996) 0.77

Binding of yeast TFIIIC to tRNA gene bipartite internal promoters: analysis of physical effects on the intervening DNA. Biochem Biophys Res Commun (1991) 0.75

[Problem areas in nursing. 1]. Krankenpflege (Frankf) (1983) 0.75

Analysis of conserved positions in nuclear RNase P RNA. Nucleic Acids Symp Ser (1995) 0.75

Instant inservice: a poster program. J Nurs Staff Dev (1988) 0.75

[Problem areas in nursing. 2]. Krankenpflege (Frankf) (1983) 0.75

Fireworks-related injuries, King County, Washington, 1983 to 1985. JAMA (1986) 0.75